Yana Najjar
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Hypoxia in Primary Melanoma (NCT06831071) | Yana Najjar | 2025-04-09 |
| RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis (NCT06216938) | Yana Najjar | 2024-03-07 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
| Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma (NCT04658303) | Yana Najjar | 2021-02-24 |
| Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma (NCT04493203) | Yana Najjar | 2020-12-18 |
| A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma (NCT03311308) | Yana Najjar | 2018-02-07 |
Track Yana Najjar automatically
Every clearance here is in the API, with alerts when new ones post.